Teva submits NDA for ecopipam to treat pediatric Tourette syndrome
Go back to Teva submits NDA for ecopipam to treat pediatric Tourette syndrome| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 31.18 +1.03 (3.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.15 | 52 Week High | $66.55 | |||
| Open | $29.94 | 52 Week Low | $37.82 | |||
| Day High | $31.20 | P/E | N/A | |||
| Day Low | $29.60 | EPS | $0.00 | |||
| Volume | 4,451,647 | |||||
